Home | Publications | Research (R&D) | Pipeline place holder
place holder place holder

Pipeline


Interleukin Genetics Incorporated Product Pipeline Analysis


Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   38
ISBN Number   not applicable
Product Code   GMD669
Ask a question about this product?

Price £505.00

approximately: $753 | €602

Summary


This report is an insightful source for data, analysis and strategic insights into a Interleukin Genetics Incorporated's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Industry Outlook - In Vitro Diagnostics
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Major Products and Services
      • 3.2.1 Overview
  • 4 Competitors
  • 5 Key Employees
  • 6 Key Employee Biographies
  • 7 Company Statement
  • 8 Locations And Subsidiaries
    • 8.1 Head Office
    • 8.2 Other Locations & Subsidiaries
  • 9 Recent Developments
    • 9.1 Financial Announcements
      • 9.1.1 Aug 13, 2008: Interleukin Reports 2Q 2008 Results
      • 9.1.2 May 14, 2008: Interleukin Reports Q1 2008 Results
      • 9.1.3 Mar 27, 2008: Interleukin Declares Q4 2007 Results
      • 9.1.4 Nov 07, 2007: Interleukin Declares Q3 2007 Results
      • 9.1.5 Aug 09, 2007: Interleukin Declares Q2 2007 Results
      • 9.1.6 May 09, 2007: Interleukin Declares Q1 2007 Results
      • 9.1.7 Apr 02, 2007: Interleukin Declares Q4 2006 Results
      • 9.1.8 Nov 08, 2006: Interleukin Declares Q3 2006 Results
    • 9.2 Corporate Communications
      • 9.2.1 Aug 05, 2008: Interleukin Appoints Senior Director, Business Development
      • 9.2.2 Jul 28, 2008: Interleukin Announces Board Changes
      • 9.2.3 Apr 30, 2008: Interleukin Appoints New CFO
      • 9.2.4 Jan 23, 2008: Interleukin Appoints New CEO
      • 9.2.5 Sep 06, 2007: Interleukin Announces Management And Board Appointments
      • 9.2.6 Jul 03, 2007: Interleukin Announces Executive Management And Board Changes
    • 9.3 Product News
      • 9.3.1 Aug 13, 2008: Interleukin Genetics Licenses Its PST Genetic Test To OralDNA Labs
      • 9.3.2 Jul 22, 2008: Interleukin Genetics Launches Enhanced Heart Health Genetic Test
      • 9.3.3 Jun 21, 2006: Interleukin Genetics Licenses DNA-Based Weight Management Technology From GeneOb
  • 10 Interleukin Genetics Incorporated Pipeline Products
    • 10.1 Interleukin Genetics Incorporated Product Pipeline Analysis
      • 10.1.1 Interleukin Genetics Incorporated Pipeline Products By Equipment Type
      • 10.1.2 Interleukin Genetics Incorporated Pipeline Products By Development Stage
      • 10.1.3 Interleukin Genetics Incorporated Pipeline Products By Therapy Area
      • 10.1.4 Interleukin Genetics Incorporated Pipeline Products By News Summary
    • 10.2 Osteoporosis genetic test
      • 10.2.1 Product Description
      • 10.2.2 Product Status
    • 10.3 Weight management genetic test
      • 10.3.1 Product Description
      • 10.3.2 Product Status
      • 10.3.3 Product Milestone
    • 10.4 Skin Aging genetic test
      • 10.4.1 Product Description
      • 10.4.2 Product Status
    • 10.5 General nutrition genetic test
      • 10.5.1 Product Description
      • 10.5.2 Product Status
    • 10.6 IL1 Cardiovascular genetic test
      • 10.6.1 Product Description
      • 10.6.2 Product Status
  • 11 Appendix
    • 11.1 Methodology
      • 11.1.1 Coverage
      • 11.1.2 Secondary Research
      • 11.1.3 Primary Research
      • 11.1.4 Expert Panel Validation
    • 11.2 Contact Us
    • 11.3 About Global Markets Direct
    • 11.4 Disclaimer
  • 1 List of Tables
    • Table 1: Interleukin Genetics Incorporated,Key Facts
    • Table 2: Interleukin Genetics Incorporated, Key Employees,
    • Table 3: Interleukin Genetics Incorporated, Other Locations
    • Table 4: Interleukin Genetics Incorporated Pipeline Products by Equipment Type
    • Table 5: Interleukin Genetics Incorporated Pipeline Products By Development Stage
    • Table 6: Interleukin Genetics Incorporated Pipeline Products By Therapy Area
    • Table 7: Interleukin Genetics Incorporated Pipeline Products By News Summaries
    • 1.2 List of Figures
    • Figure 1: Interleukin Genetics Incorporated Pipeline Products By Development Stage
    • Figure 2: Global Markets Direct Methodology